Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
Published on: January 19, 2024
A mechanism based approach to management of children with end-stage liver disease
1a Pediatric Transplant Hepatology, Organ Transplant and Hepatobiliary Surgery , King Abdullah Specialized Children Hospital , Riyadh , KSA.
Insights
Optimizing pre-transplant care for children with end-stage liver disease (ESLD) is crucial for successful liver transplantation (LT). This review details management strategies for ESLD complications to improve pediatric LT outcomes.
Area of Science:
- Pediatric Hepatology
- Transplantation Medicine
- Gastroenterology
Background:
- Liver transplantation (LT) has significantly improved outcomes for children with end-stage liver disease (ESLD).
- Pre-transplant management of ESLD complications remains a significant challenge despite advances in surgical and acute care.
- Organ shortage and increasing survival expectations necessitate sophisticated pre-transplant strategies.
Purpose of the Study:
- To provide mechanism-based management strategies for common ESLD complications in children.
- To guide the formulation of pre-transplant management plans for pediatric liver transplantation.
- To enhance outcomes of pediatric liver transplantation through optimized pre-transplant care.
Main Methods:
- Review of current literature on ESLD management strategies.
- Discussion of pathophysiologic mechanisms underlying ESLD complications.
- Identification of high-impact therapeutic interventions for pre-transplant care.
Main Results:
- Detailed strategies for managing malnutrition, altered metabolic pathways, gastrointestinal dysfunction, and ascites in pediatric ESLD.
- Clinically relevant discussions linking mechanisms to therapeutic interventions.
- A tabulated summary of suggested interventions for pre-transplant management.
Conclusions:
- A dynamic, tailored pre-transplant management plan is essential for improving pediatric LT outcomes.
- Sophisticated management of pre-transplant ESLD presents a major opportunity to enhance the future of pediatric LT.
- Addressing ESLD complications proactively can significantly impact graft and patient survival post-transplantation.
Introduction:
Due to parallel advances in surgical and acute care disciplines, liver transplantation (LT) has revolutionized the outlook for children with end-stage liver disease (ESLD). Contrary to advances in technical aspects of LT and the peri-operative care, pre-transplant management of ESLD remains quite a formidable challenge. Areas covered: This review provides mechanisms based management strategies to address common complications of ESLD including malnutrition, amended metabolic pathways, gastrointestinal dysfunction, and development of ascites. Clinically relevant discussion of each paradigm is followed by an account of high impact therapeutic interventions which can be used as guides for formulating management plans. A tabulated summary of the suggested interventions is also provided. Indeed, execution of a dynamic plan tailored to the evolution of pathophysiologic derangements can further enhance outcomes of pediatric LT. Expert commentary: LT has evolved as a dependable therapeutic option for a variety of fatal pediatric liver diseases. However, relative organ shortage remains a formidable challenge. Similarly, consumer expectations continue to grow for sustained improvement of graft and patient survival after LT. In this environment, the level of sophistication applied to the management ESLD before LT stands out as a major opportunity with lasting impact on the future of pediatric LT.
More Related Videos
09:54Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...